Virtu Financial’s Palvella Therapeutics PVLA Stock Holding History

Virtu Financial’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$963K	Buy	+7,726	New	+$806K	0.04%	316
2024 Q1	–	Sell	-1,126	Closed	-$16K	–	2219
2023 Q4	$16K	Buy	+1,126	New	+$20.6K	﹤0.01%	1355
2022 Q4	–	Sell	-171	Closed	-$16K	–	2236
2022 Q3	$16K	Buy	+171	New	+$22K	﹤0.01%	1451
2021 Q1	–	Sell	-239	Closed	-$48K	–	2113
2020 Q4	$48K	Buy	+239	New	+$49.7K	0.01%	1238
2019 Q4	–	Sell	-809	Closed	-$221K	–	1931
2019 Q3	$221K	Buy	+809	New	+$313K	0.02%	915
2018 Q2	–	Sell	-643	Closed	-$352K	–	2585
2018 Q1	$352K	Buy	643 +281	+78%	+$174K	0.02%	933
2017 Q4	$219K	Sell	362 -4	-1%	-$1.86K	0.01%	1586
2017 Q3	$169K	Buy	+366	New	+$156K	0.01%	1925

Other funds holding PVLA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Virtu Financial's PVLA Position: Q1 2026 in Review

Virtu Financial opened a new position in Palvella Therapeutics (PVLA) in Q1 2026: 7,726 shares worth $963K. The stake represents 0.04% of the portfolio and ranks #316 among its holdings. This is a return to the name: Virtu Financial previously reported a position in PVLA as recently as Q4 2023.

Virtu Financial first reported a position in PVLA in Q3 2017 and has held it in 8 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

Virtu Financial held 7,726 shares of Palvella Therapeutics worth $963K as of Q1 2026.
Palvella Therapeutics was a new Virtu Financial position in Q1 2026.
Palvella Therapeutics made up 0.04% of Virtu Financial's portfolio in Q1 2026, its #316 holding.
Virtu Financial first reported a position in Palvella Therapeutics in Q3 2017 and has held it in 8 quarters since.
180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.